Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | GRIA2 | P42262 | 7/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 6/20 | 0.36 |
| ▸ | GRIA3 | P42263 | 6/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 6/20 | 0.36 |
| ▸ | CES2 | O00748 | 3/20 | 0.35 |
| ▸ | CES1 | P23141 | 3/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL139098 | 0.75 | — | — | |
| SCHEMBL139164 | 0.69 | GPR3 (0.46) | CA1CA2CA12CA4CA7 | |
| SCHEMBL13469958 | 0.68 | CA12 (0.41) | CA2CA12CA9ALDH1A1ATM | |
| SCHEMBL576238 | 0.67 | CA2 (0.39) | CA1CA2CA12CA4CA7 | |
| SCHEMBL3164975 | 0.67 | CHRNA1 (0.48) | CA1CA2CA12CA4CA7 | |
| SCHEMBL8208229 | 0.60 | — | — | |
| SCHEMBL22928296 | 0.60 | KMT2A (0.40) | CA1CA2CA12CA4CA7 | |
| SCHEMBL4011978 | 0.60 | CA1 (0.54) | CA1CA2CA12CA4CA7 | |
| SCHEMBL10151532 | 0.59 | — | — | |
| SCHEMBL21031877 | 0.58 | VEGFA (0.62) | CA1CA2CA12CA4CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260031394-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2026-01-29 | — | — | US | disclosed |
| US-20260031400-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | TOMIYAMA PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2026-01-29 | — | — | US | disclosed |
| EP-4525122-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | Tomiyama Pure Chemical Industries, Limited (JP) | 2025-03-19 | — | — | EP | disclosed |
| EP-4525123-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | Tomiyama Pure Chemical Industries, Limited (JP) | 2025-03-19 | — | — | EP | disclosed |
| CN-119547248-A | Electrolyte for electric storage device, reinforcing agent, electrolyte solution, and electric storage device using same | 富山药品工业株式会社 | 2025-02-28 | — | — | CN | disclosed |
| WO-2024225237-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | 富山薬品工業株式会社 | 2024-10-31 | — | — | WO | disclosed |
| WO-2024225238-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | 富山薬品工業株式会社 | 2024-10-31 | — | — | WO | disclosed |
| CN-110870112-B | Lithium ion secondary battery | 日本电气株式会社 | 2024-09-20 | — | — | CN | disclosed |
| US-20240297344-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-05 | — | — | US | disclosed |
| CN-117525550-A | Electrolyte for power storage device and nonaqueous electrolyte | 富山药品工业株式会社 | 2024-02-06 | — | — | CN | disclosed |
| US-20100190065-A1 | ELECTROLYTE AND SECONDARY BATTERY | SONY CORPORATION (JP) | 2010-07-29 | — | — | US | disclosed |
| US-20100190065-A1 | ELECTROLYTE AND SECONDARY BATTERY | SONY CORPORATION (JP) | 2010-07-29 | — | — | US | disclosed |
| EP-2211401-A2 | Electrolyte and secondary battery | Sony Corporation (JP) | 2010-07-28 | — | — | EP | disclosed |
| EP-2211402-A2 | Electrolyte and secondary battery | Sony Corporation (JP) | 2010-07-28 | — | — | EP | disclosed |
| US-20100178569-A1 | ELECTROLYTE AND SECONDARY BATTERY | SONY CORPORATION (JP) | 2010-07-15 | — | — | US | disclosed |
| US-20100178569-A1 | ELECTROLYTE AND SECONDARY BATTERY | SONY CORPORATION (JP) | 2010-07-15 | — | — | US | disclosed |
| US-20100119956-A1 | NONAQUEOUS ELECTROLYTE FOR SECONDARY BATTERY AND NONAQUEOUS-ELECTROLYTE SECONDARY BATTERY EMPLOYING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2010-05-13 | — | — | US | disclosed |
| EP-2144321-A1 | NONAQUEOUS ELECTROLYTE FOR RECHARGEABLE BATTERY, AND RECHARGEABLE BATTERY WITH NONAQUEOUS ELECTROLYTE | Mitsubishi Chemical Corporation (JP) | 2010-01-13 | — | — | EP | disclosed |
| US-20080096112-A1 | BATTERY | SONY CORPORATION (JP) | 2008-04-24 | — | — | US | disclosed |
| US-20080096112-A1 | BATTERY | SONY CORPORATION (JP) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260031394-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | SMC1A, SMC2, SMC4 | CA1 622/4885CA2 607/4885CA12 2460/4885 |
| US-20260031400-A1 | ELECTROLYTE FOR POWER STORAGE DEVICE, REINFORCING AGENT, ELECTROLYTE SOLUTION, AND POWER STORAGE DEVICE USING SAME | KCNN1, KCNN2, ILK | CA1 588/4885CA2 600/4885CA12 2745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.